The recent finding that NPMc+ and MLL-fusion AML cell lines and primary leukemic cells have sustained activation of autophagy and that autophagy is reduced with Brd4 inhibition [10] suggested that Brd4 is a regulator of autophagy. The gene discussed is KMT2A; the disease is acute myeloid leukemia.